Fate Therapeutics Inc.

(FATE) Trade

By |

Profile

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Contact Information

Website: www.fatetherapeutics.com
Email: info@fatetherapeutics.com
Main Phone: +1 858 875-1800
Address: 3535 General Atomics Court
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSD
CEO: J. Scott Wolchko
Employees: 178
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Contact Information

Website: www.fatetherapeutics.com
Email: info@fatetherapeutics.com
Main Phone: +1 858 875-1800
Address: 3535 General Atomics Court
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: NSD
CEO: J. Scott Wolchko
Employees: 178
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 37.09 $ 0.03 (0.08%)
Last Price 37.09 Change $ 0.03 Change % 0.08 Tick N/A
Bid 36.10 Bid Size 100.00 Ask 38.60 Ask Size 100.00
Open 36.98 High 37.26 Low 35.40 Prev Close 37.06
Last Trade Volume 1.3 mi 52 Wk Hi 39.45 52 Wk Low 12.60
Market Cap 3.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 86,844,029.00 EPS (TTM) -1.57 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 8
Number of Buys 2 2
Number of Sells 0 6
Net Activity 21054 -17430
Last 10 Buys Shares
Chris Storgard 1,000
William H. Rastetter 1,000
Timothy P. Coughlin 1,000
John D. Mendlein 1,000
William H. Rastetter 1,000
Robert T. Nelsen 1,000
Amir Nashat 1,000
Amir Nashat 1,000
Amir Nashat 1,000
Amir Nashat 1,000
Last 10 Sell Shares
J. Scott Wolchko 1,000
Cindy Tahl 1,000
Daniel D. Shoemaker 1,000
J. Scott Wolchko 1,000
Daniel D. Shoemaker 1,000
Cindy Tahl 1,000
Peter Flynn 1,000
Peter Flynn 1,000
Peter Flynn 1,000
Peter Flynn 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 17.8 17.8 17.8 17.8
Standard Deviation 3.35 3.35 3.35 3.35
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.67 1.67